Immunotherapy tackles lupus

Nature Medicine

Volumn 8, Issue 12, 2002, Pages 1356-1358

  Kammer, Gary M ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYCLOPHOSPHAMIDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD137; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; IMMUNOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD137; B-LYMPHOCYTES; IMMUNOTHERAPY; INTERFERON TYPE II; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED MRL LPR; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; T-LYMPHOCYTES;

ANIMALIA;

EID: 0036917862     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1202-1356     Document Type: Short Survey

References (11)

1. Sun, Y. et al. Therapeutic treatment of a spontaneous autoimmune disease with an agonistic monoclonal antibody against a costimulatory molecule. Nature Med. 8, 1405-1413 (2002).
2. Shlomchik, M.J., Craft, J.E. & Mamula, M.I. From T to B and back again: Positive feedback in systemic autoimmune disease. Nature Rev. Immunol. 1, 147-153 (2001).
3. Kammer, G.M., Perl, A., Richardson, B.C. & Tsokos, G.C. Abnormal T cell signal transduction in systemic lupus erythematosus, Arthritis Rheum. 46, 1139-1154 (2002).
4. Oates, J.C. & Gilkeson, G.S. Mediators of injury in lupus nephritis. Curr. Opin. Rheumotol. 14, 498-503 (2002).
5. Sica, G. & Chen, L., Modulation of the immune response through 4-1BB. Adv. Exp. Med. Biol. 465, 355-362 (2000).
6. Ye, Z. et al. Gene therapy for cancer using singlechain Fv fragments specific for 4-1BB. Nature Med. 8, 343-348 (2002).
7. + T cell responses. Nature Immunol. 3, 536-541 (2002).
8. Balomenos, D., Rumold, R. & Theofilopoulos, A.N. Interferon-γ is required for lupus-like disease and lymphoaccumulation in MRL-Ipr mice. J. Clin. Invest. 101, 364-371 (1998).
9. Nicoletti, F. et al. Dichotomic effects of IFN-γ on the development of systemic lupus erythematosus-like syndrome in MRL-Ipr/lpr mice. Eur. Immunol. 30, 438-447 (2000).
10. Seo, S., Mandik-Nayak, L. & Erikson, J. B cell anergy and systemic lupus erythematosus. Curr. Dir. Autoimmun. 6, 1-20 (2003).
11. Gescuk, B.D. & Davis, J.C. Jr. Novel therapeutic agents for systemic lupus erythematosus. Curr. Opin. Rheumotol. 14, 515-521 (2002).